3-iodo-alpha-methyltyrosine has been researched along with iomethin in 1 studies
| Studies (3-iodo-alpha-methyltyrosine) | Trials (3-iodo-alpha-methyltyrosine) | Recent Studies (post-2010) (3-iodo-alpha-methyltyrosine) | Studies (iomethin) | Trials (iomethin) | Recent Studies (post-2010) (iomethin) |
|---|---|---|---|---|---|
| 83 | 9 | 1 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bubeck, B; Eisenhut, M; Heimke, U; zum Winkel, K | 1 |
1 other study(ies) available for 3-iodo-alpha-methyltyrosine and iomethin
| Article | Year |
|---|---|
Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Cricetinae; Eye Neoplasms; Iodine Radioisotopes; Male; Melanoma; Mesocricetus; Methyltyrosines; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution | 1981 |